2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy …
Guidelines, Aspirin, Clopidogrel, Ticagrelor, Prasugrel, Dual antiplatelet therapy, Acute
coronary syndromes, Coronary artery bypass grafting, Coronary artery disease, Drug-eluting …
coronary syndromes, Coronary artery bypass grafting, Coronary artery disease, Drug-eluting …
Continuation versus discontinuation of antiplatelet therapy for bleeding and ischaemic events in adults undergoing non‐cardiac surgery
SR Lewis, MW Pritchard… - Cochrane Database …, 2018 - cochranelibrary.com
Background Antiplatelet agents are recommended for people with myocardial infarction and
acute coronary syndromes, transient ischaemic attack or stroke, and for those in whom …
acute coronary syndromes, transient ischaemic attack or stroke, and for those in whom …
[HTML][HTML] Management of antiplatelet therapy in patients undergoing elective invasive procedures: proposals from the French Working Group on perioperative …
A Godier, P Fontana, S Motte, A Steib… - Archives of …, 2018 - Elsevier
Antiplatelet drugs are prescribed to prevent arterial thrombosis and especially the
recurrence of thrombotic events. The four main oral antiplatelets have two distinct …
recurrence of thrombotic events. The four main oral antiplatelets have two distinct …
Aspirin in patients with previous percutaneous coronary intervention undergoing noncardiac surgery
MM Graham, DI Sessler, JL Parlow… - Annals of internal …, 2018 - acpjournals.org
Background: Uncertainty remains about the effects of aspirin in patients with prior
percutaneous coronary intervention (PCI) having noncardiac surgery. Objective: To evaluate …
percutaneous coronary intervention (PCI) having noncardiac surgery. Objective: To evaluate …
Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, Sedar, Seacv, Sectcv, Aec, Secpre, Sepd, Sego, Sehh, Seth …
During the last few years, the number of patients receiving anticoagulant and antiplatelet
therapy has increased worldwide. Since this is a chronic treatment, patients receiving it can …
therapy has increased worldwide. Since this is a chronic treatment, patients receiving it can …
Manejo perioperatorio y periprocedimiento del tratamiento antitrombótico: documento de consenso de SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO …
En los últimos años, el número de pacientes anticoagulados y antiagregados está
aumentando significativamente. Al ser un tratamiento crónico, es de esperar que a lo largo …
aumentando significativamente. Al ser un tratamiento crónico, es de esperar que a lo largo …
Consensus document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: long-term antiplatelet therapy in patients with coronary artery disease
Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibitor is the
cornerstone of pharmacologic management of patients with acute coronary syndrome (ACS) …
cornerstone of pharmacologic management of patients with acute coronary syndrome (ACS) …
[HTML][HTML] Gestion des agents antiplaquettaires pour une procédure invasive programmée. Propositions du Groupe d'intérêt en hémostase périopératoire (GIHP) et du …
A Godier, P Fontana, S Motte, A Steib… - Anesthésie & …, 2018 - Elsevier
Résumé Le Groupe d'intérêt en hémostase périopératoire (GIHP) et le Groupe français
d'études sur l'hémostase et la thrombose (GFHT), en collaboration avec la Société française …
d'études sur l'hémostase et la thrombose (GFHT), en collaboration avec la Société française …
[HTML][HTML] Interventional cardio-oncology: adding a new dimension to the cardio-oncology field
VY Liu, AM Agha, J Lopez-Mattei… - Frontiers in …, 2018 - frontiersin.org
The management of cardiovascular disease in patients with active cancer presents a unique
challenge in interventional cardiology. Cancer patients often suffer from significant …
challenge in interventional cardiology. Cancer patients often suffer from significant …
[PDF][PDF] Documento di consenso intersocietario ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: La terapia antiaggregante a lungo termine nel paziente con malattia …
Although current European Society of Cardiology guidelines provide backup to individualize
treatment, it seems difficult to identify the ideal patient profile who could safely reduce or …
treatment, it seems difficult to identify the ideal patient profile who could safely reduce or …